51
|
Granrud M, Tan N, Arruda-Olson A, Noseworthy P, Jackson C. DIAGNOSING CARDIAC SARCOIDOSIS: FINDING THE NEEDLE IN THE HAYSTACK. J Am Coll Cardiol 2019. [DOI: 10.1016/s0735-1097(19)33398-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
52
|
Yao X, Shah N, Gersh B, Noseworthy P. TEN-YEAR POPULATION TRENDS IN STATIN THERAPY FOR SECONDARY PREVENTION: USE, ADHERENCE, COST, AND OUTCOMES. J Am Coll Cardiol 2019. [DOI: 10.1016/s0735-1097(19)32340-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
53
|
Dubose-Briski V, Yao X, Dunlay S, Dhruva S, Ross J, Shah N, Noseworthy P. EVOLUTION OF THE AMERICAN COLLEGE OF CARDIOLOGY AND THE AMERICAN HEART ASSOCIATION CARDIOLOGY CLINICAL PRACTICE GUIDELINES: A 10-YEAR ASSESSMENT. J Am Coll Cardiol 2019. [DOI: 10.1016/s0735-1097(19)33634-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
54
|
Schram M, Shreibati JB, Bos M, Galloway C, Valys A, Petterson F, Gundotra V, Albert D, Attia ZI, Noseworthy P, Friedman P, Ackerman M. PREDICTION OF THE HEART RATE CORRECTED QT INTERVAL (QTC) FROM A NOVEL, MULTILEAD SMARTPHONE-ENABLED ECG USING A DEEP NEURAL NETWORK. J Am Coll Cardiol 2019. [DOI: 10.1016/s0735-1097(19)30976-3] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
55
|
El-Am E, Dispenzieri A, Grogan M, Ammash N, Melduni R, White R, Hodge D, Noseworthy P, Lin G, Pislaru S, Nkomo V. P2925Outcomes of direct current cardioversion in adults with cardiac amyloidosis. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy565.p2925] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
56
|
Naksuk N, Desimone C, Witt C, Sugrue A, Kella D, Noseworthy P. P5792Risks factors for dofetilide-associated torsades de pointes among hospitalized patients with atrial fibrillation. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy566.p5792] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
57
|
Giudicessi J, Noseworthy P, Kappa S, McLeod C, Cannon B, Asirvatham S, Ackerman M. 5921Premature ventricular contraction-triggered ventricular fibrillation: an under-recognized mechanism of sudden cardiac arrest in the young. Eur Heart J 2018. [DOI: 10.1093/eurheartj/ehy566.5921] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
58
|
Siontis K, Eckard A, Bhave N, Noseworthy P, Shah N, Yao X, He K, Stack A, Balkrishnan R, Saran R, Nallamothu B. USE OF DIRECT ORAL ANTICOAGULANTS IN DIALYSIS PATIENTS WITH ATRIAL FIBRILLATION IN THE UNITED STATES. J Am Coll Cardiol 2018. [DOI: 10.1016/s0735-1097(18)31053-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
59
|
Yao X, Gersh B, Sangaralingham L, Shah N, Noseworthy P. DO COMPASS TRIAL PARTICIPANTS REPRESENT PATIENTS IN EVERYDAY PRACTICE? J Am Coll Cardiol 2018. [DOI: 10.1016/s0735-1097(18)30572-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/17/2022]
|
60
|
Agnihotri K, Pothineni N, Charilaou P, Vaidya VR, Thakkar B, Goyal V, Kadavath S, Patel N, Badheka A, Noseworthy P, Kapa S, Friedman P, Gersh B, Paydak H, Deshmukh A. Impact of atrial fibrillation on outcomes with motor vehicle accidents. Int J Cardiol 2018; 250:128-132. [DOI: 10.1016/j.ijcard.2017.10.002] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 06/07/2017] [Revised: 09/07/2017] [Accepted: 10/02/2017] [Indexed: 11/30/2022]
|
61
|
Noseworthy P, Yao X, Tangri N, Shah N, Nath K. 5715Anticoagulant use and associated outcomes in patients with atrial fibrillation and advanced kidney disease. Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx493.5715] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
62
|
Johnsrud D, Lahr B, Melduni R, Noseworthy P. P508Does empiric atrial appendage closure in patients with atrial fibrillation impact rates of late withdrawal of anticoagulation and does this affect subsequent stroke incidence. Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx501.p508] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
63
|
Noseworthy P, Yao X, Sangaralingham L, Shah N. 5716Age and gender differences in stroke and bleeding risks in atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants. Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx493.5716] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
64
|
Noseworthy P, Yao X, Shah N. P4019The impact of age on the effectiveness and safety of the NOACs versus warfarin for stroke prevention in atrial fibrillation. Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx504.p4019] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
65
|
Noseworthy P, Yao X, Shah N. P6246Utilization and effectiveness of alirocumab and evolocumab in improving lipid profile in routine clinical practice. Eur Heart J 2017. [DOI: 10.1093/eurheartj/ehx493.p6246] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
66
|
Schleifer J, Manocha K, Asirvatham S, Noseworthy P, Friedman P, Madhavan M, Gulati R, Munger T, Cooper L, Kapa S. P1058Safety of performing radiofrequency catheter ablation and endomyocardial biopsy in the same setting. Europace 2017. [DOI: 10.1093/ehjci/eux151.237] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
67
|
Bhatia S, Mallam S, Singh V, Agnihotri K, Arora S, Patel P, Noseworthy P, Kapa S, Panaich S, Patel N, Badheka A, Patel N, Deshmukh A. ATRIAL FIBRILLATION IS ASSOCIATED WITH WORSE OUTCOMES IN PATIENTS WITH CIRRHOSIS. J Am Coll Cardiol 2017. [DOI: 10.1016/s0735-1097(17)33882-2] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
68
|
Yao X, Tangri N, Sangaralingham L, Shah N, Noseworthy P. A COMPARISON OF KIDNEY FUNCTION DECLINE IN ATRIAL FIBRILLATION PATIENTS TREATED WITH NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS OR WARFARIN. J Am Coll Cardiol 2017. [DOI: 10.1016/s0735-1097(17)35957-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
69
|
Patel NJ, Deshmukh A, Pau D, Goyal V, Patel SV, Patel N, Agnihotri K, Asirvatham S, Noseworthy P, Di Biase L, Natale A, Viles-Gonzalez JF. Contemporary utilization and safety outcomes of catheter ablation of atrial flutter in the United States: Analysis of 89,638 procedures. Heart Rhythm 2016; 13:1317-25. [DOI: 10.1016/j.hrthm.2016.02.005] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/05/2016] [Indexed: 11/25/2022]
|
70
|
Kapa S, Noseworthy P, Asirvatham S. UTILITY OF PRE-PROCEDURAL IMAGING IN PREDICTING DIAGNOSTIC YIELD OF VOLTAGE GUIDED BIOPSIES. J Am Coll Cardiol 2016. [DOI: 10.1016/s0735-1097(16)31542-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
71
|
Noseworthy P, Yao X, Sangaralingham LR, Abraham N, McBane R, Gersh B, Shah N. DIRECT COMPARISON OF DABIGATRAN, RIVAROXABAN, AND APIXABAN FOR EFFECTIVENESS AND SAFETY IN NONVALVULAR ATRIAL FIBRILLATION. J Am Coll Cardiol 2016. [DOI: 10.1016/s0735-1097(16)30693-3] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
72
|
Nordhues B, Siontis K, Scott C, Nkomo V, Ackerman M, Asirvatham S, Noseworthy P. BILEAFLET MITRAL VALVE PROLAPSE AND THE RISK OF VENTRICULAR DYSRHYTHMIAS AND DEATH. J Am Coll Cardiol 2016. [DOI: 10.1016/s0735-1097(16)30683-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
73
|
Patel NJ, Edla S, Deshmukh A, Nalluri N, Patel N, Agnihotri K, Patel A, Savani C, Patel N, Bhimani R, Thakkar B, Arora S, Asti D, Badheka AO, Parikh V, Mitrani RD, Noseworthy P, Paydak H, Viles-Gonzalez J, Friedman PA, Kowalski M. Gender, Racial, and Health Insurance Differences in the Trend of Implantable Cardioverter-Defibrillator (ICD) Utilization: A United States Experience Over the Last Decade. Clin Cardiol 2016; 39:63-71. [PMID: 26799597 DOI: 10.1002/clc.22496] [Citation(s) in RCA: 38] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/19/2015] [Revised: 11/01/2015] [Indexed: 12/28/2022] Open
Abstract
Prior studies have highlighted disparities in cardiac lifesaving procedure utilization, particularly among women and in minorities. Although there has been a significant increase in implantable cardioverter-defibrillator (ICD) insertion, socioeconomic disparities still exist in the trend of ICD utilization. With the use of the Nationwide Inpatient Sample from 2003 through 2011, we identified subjects with ICD insertion (procedure code 37.94) and cardiac resynchronization defibrillator (procedure code 00.50, 00.51) as codified by the International Classification of Diseases, Ninth Revision, Clinical Modification. Overall, 1 020 076 ICDs were implanted in the United States from 2003 to 2011. We observed an initial increase in ICD utilization by 51%, from 95 062 in 2003 to 143 262 in 2006, followed by a more recent decline. The majority of ICDs were implanted in men age ≥65 years. Implantation of ICDs was 2.5× more common in men than in women (402 per million vs 163 per million). Approximately 95% of the ICDs were implanted in insured patients, and 5% were used in the uninsured population. There has been a significant increase in ICD implantation in blacks, from 162 per million in 2003 to 291 per million in 2011. We found a significant difference in the volume of ICD implants between the insured and the uninsured patient populations. Racial disparities have narrowed significantly in comparison with those noted in earlier studies and are now more reflective of the population demographics at large. On the other hand, significant gender disparities continue to exist.
Collapse
|
74
|
Sugrue A, Kremen V, Qiang B, Sheldon S, DeSimone C, Asirvatham S, Friedman P, Ackerman M, Noseworthy P. 10 Electrocardiographic predictors of torsadogenic risk during dofetilide or sotalol initiation: utility of a novel T wave analysis programme. BRITISH HEART JOURNAL 2015. [DOI: 10.1136/heartjnl-2015-308621.10] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
75
|
Noseworthy P, Deshmukh A, Lindsey H, Holly VH, Sara S, Shah N, Kapa S, Friedman P, Packer D, Asirvatham S. FREQUENCY AND PREDICTORS OF PACEMAKER IMPLANTATION AFTER CATHETER ABLATION OR CARDIOVERSION FOR ATRIAL FIBRILLATION. J Am Coll Cardiol 2015. [DOI: 10.1016/s0735-1097(15)60309-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
76
|
Deshmukh A, Patel A, Patel N, Thakkar B, Solanki S, Patel S, Arora S, Patel N, Nalluri N, Noseworthy P, Pant S, Reddy Y, Badheka A, Witt C, Cha YM, Friedman P, Asirvatham S. UTILIZATION AND SAFETY OF CARDIAC RESYNCHRONIZATION THERAPY IN ELDERLY. J Am Coll Cardiol 2015. [DOI: 10.1016/s0735-1097(15)60909-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
77
|
Jena AB, Romley JA, Newton-Cheh C, Noseworthy P. Therapeutic hypothermia for cardiac arrest: real-world utilization trends and hospital mortality. J Hosp Med 2012; 7:684-9. [PMID: 23023977 PMCID: PMC3515738 DOI: 10.1002/jhm.1974] [Citation(s) in RCA: 21] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/17/2012] [Revised: 07/11/2012] [Accepted: 07/25/2012] [Indexed: 01/19/2023]
Abstract
BACKGROUND Therapeutic hypothermia (TH) improves outcomes following cardiac arrest in small clinical trials. OBJECTIVE To study real-world utilization and outcomes in US hospitals. DESIGN Retrospective cohort study. SETTING California hospitals. PATIENTS Patients eligible for therapeutic hypothermia after cardiac arrest. INTERVENTIONS We analyzed all discharges from California (1999-2008) to identify patients eligible for TH after cardiac arrest. Patients were considered eligible for TH if both cardiac arrest and anoxic brain injury were among the administrative diagnoses (n = 46,833). Patients undergoing TH (n = 204) were identified through billing codes. MEASUREMENTS TH utilization and in-hospital mortality. RESULTS Use of TH increased over the study period with 87.3% (178/204) of TH occurring between 2006 and 2008. Few hospitals appeared to perform TH over the study period (47/419, 11.2%). Utilization of TH was concentrated in a few centers, with the top 3 of 419 centers accounting for 31.4% (64/204) of cases. Patients undergoing TH were younger, less likely to be male, more likely to be treated at teaching centers, and had similar comorbidities compared to eligible individuals who did not undergo TH. The adjusted odds ratio for hospital mortality among patients undergoing TH was 0.80 (95% confidence interval [CI] 0.60-1.06, P = 0.11). CONCLUSIONS TH utilization appears low, but implementation is increasing. Case selection and referral biases limit the analysis of the relationship between center TH volume and in-hospital mortality.
Collapse
|
78
|
Yared K, Noseworthy P, Weyman AE, McCabe E, Picard MH, Baggish AL. Pulmonary artery acceleration time provides an accurate estimate of systolic pulmonary arterial pressure during transthoracic echocardiography. J Am Soc Echocardiogr 2011; 24:687-92. [PMID: 21511434 DOI: 10.1016/j.echo.2011.03.008] [Citation(s) in RCA: 122] [Impact Index Per Article: 9.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/13/2010] [Indexed: 11/28/2022]
Abstract
BACKGROUND Transthoracic echocardiographic estimates of peak systolic pulmonary artery pressure are conventionally calculated from the maximal velocity of the tricuspid regurgitation (TR) jet. Unfortunately, there is insufficient TR to determine estimated peak systolic pulmonary artery pressure (EPSPAP) in a significant number of patients. To date, in the absence of TR, no noninvasive method of deriving EPSPAP has been developed. METHODS Five hundred clinically indicated transthoracic echocardiograms were reviewed over a period of 6 months. Patients with pulmonic stenosis were excluded. Pulsed-wave Doppler was used to measure pulmonary artery acceleration time (PAAT) and right ventricular ejection time. Continuous-wave Doppler was used to measure the peak velocity of TR (TR(Vmax)), and EPSPAP was calculated as 4 × TR(Vmax)(2) + 10 mm Hg (to account for right atrial pressure). The relationship between PAAT and EPSPAP was then assessed. RESULTS Adequate imaging to measure PAAT was available in 99.6% of patients (498 of 500), but 25.3% (126 of 498) had insufficient TR to determine EPSPAP, and 1 patient had significant pulmonic stenosis. Therefore, 371 were included in the final analysis. Interobserver variability for PAAT was 0.97. There were strong inverse correlations between PAAT and TR(Vmax) (r = -0.96), the right atrial/right ventricular pressure gradient (r = -0.95), and EPSPAP (r = -0.95). The regression equation describing the relationship between PAAT and EPSPAP was log(10)(EPSPAP) = -0.004 (PAAT) + 2.1 (P < .001). CONCLUSIONS PAAT is routinely obtainable and correlates strongly with both TR(Vmax) and EPSPAP in a large population of randomly selected patients undergoing transthoracic echocardiography. Characterization of the relationship between PAAT and EPSPAP permits PAAT to be used to estimate peak systolic pulmonary artery pressure independent of TR, thereby increasing the percentage of patients in whom transthoracic echocardiography can be used to quantify pulmonary artery pressure.
Collapse
|
79
|
Noseworthy P, Porthan K, Tikkanen J, Peloso G, Merchant F, Pietila A, Havulinna A, Oikarinen L, Hwang SJ, O'Donnell C, Salomaa V, Newton-Cheh C, Huikuri H. THE EARLY REPOLARIZATION PATTERN: CLINICAL CORRELATES AND HERITABILITY. J Am Coll Cardiol 2011. [DOI: 10.1016/s0735-1097(11)60109-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|